Narcobarbital

Today, Narcobarbital remains a topic of great relevance and interest to many people around the world. Whether due to its impact on society, its importance in history, its influence on culture or its relevance today, Narcobarbital continues to be the object of analysis, debate and reflection. Over the years, Narcobarbital has been extensively researched and written about, offering different perspectives and approaches to better understand its meaning and scope. In this article, we will explore some of the most relevant facets of Narcobarbital and reflect on its importance in our daily lives.

Narcobarbital
Clinical data
ATC code
Identifiers
  • 5-(2-bromoprop-2-en-1-yl)-5-isopropyl-1-methylpyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC11H15BrN2O3
Molar mass303.156 g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)NC(=O)C1(CC(\Br)=C)C(C)C)C
  • InChI=1S/C11H15BrN2O3/c1-6(2)11(5-7(3)12)8(15)13-10(17)14(4)9(11)16/h6H,3,5H2,1-2,4H3,(H,13,15,17) checkY
  • Key:WGMASVSHOSNKMF-UHFFFAOYSA-N checkY
  (verify)

Narcobarbital (Pronarcon) is a barbiturate derivative developed in 1932 by Carl Heinrich Friedrich Boedecker and Heinrich Gruber Schoneberg, assignors to the firm J. D. Riedel-E. de Haën AG, Berlin, Germany. Later, in 1937, may, was patented in United States. It is an N-methylated derivative of propallylonal and has similar sedative effects. It is still used in veterinary medicine for inducing surgical anaesthesia.

References

  1. ^ US 2080071, "Tri-substituted barbituric acid", issued 11 May 1937, assigned to J. D. Riedel-E. de Haën AG. 
  2. ^ Committee for Veterinary Medicinal Products (1999). "Position Paper on availability of Veterinary Medicines agreed on 17 March 1999" (PDF). The European Medicines Agency. pp. 3–8. Archived from the original (PDF) on 18 December 2014.


Stub icon

This sedative-related article is a stub. You can help Wikipedia by expanding it.

Wikious
Boobota
Sagapedia